Shari Annes | IR |
Rachel King | CEO |
Brian Hahn | SVP & CFO |
Helen Thackray | SVP, Clinical Development & CMO |
John Magnani | Co-Founder & CSO |
Ed White | H.C. Wainwright |
Ellen Sands | Stifel |
Zegbeh Jallah | ROTH Capital Partners |
Good morning and thank you all for joining GlycoMimetics Corporate Update Conference Call. At this time, all participants are in a listen-only mode.
Following management's remarks, we will hold a brief question-and-answer session, and at that time the lines will be open for you. [Operator Instructions]. I would now like to turn the call over to Ms.